HMGB1 and breast cancer: Recently, Chen et al. presented evidence indicating that HMGB1 secreted from breast cancer cells could induce fibroblast activation via its receptor, the receptor for advanced glycation end-products (RAGE), leading to the upregulation of aerobic glycolysis [161].